ZNTL icon

Zentalis Pharmaceuticals

110 hedge funds and large institutions have $1.15B invested in Zentalis Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0.05% more ownership

Funds ownership: 112.74%112.79% (+0.05%)

11% less capital invested

Capital invested by funds: $1.29B → $1.15B (-$140M)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
110
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$608K
Puts
$471K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$5.81M
27
$5.74M
28
$5.55M
29
$5.16M
30
$5.11M
31
$4.67M
32
$4.6M
33
$4.27M
34
$4.02M
35
$3.93M
36
$3.59M
37
$3.51M
38
$3.35M
39
$3.25M
40
$2.68M
41
$2.54M
42
$1.97M
43
$1.69M
44
$1.55M
45
$1.43M
46
$1.42M
47
$1.38M
48
$1.36M
49
$1.29M
50
$1.28M